CCI
INFI

Columbus Circle Investors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Columbus Circle Investors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,857
Closed -$316K – 339
2013
Q4 		$316K Sell
22,857
-86,084
-79% -$1.22M ﹤0.01% 285
2013
Q3 		$1.9M Buy
108,941
+6,686
+7% +$128K 0.01% 271
2013
Q2 		$1.66M Buy
+102,255
New +$3.16M 0.01% 255

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Columbus Circle Investors's INFI Position: Q1 2014 in Review

Columbus Circle Investors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2014, closing a stake of 22,857 shares — an estimated $316K sold.

Columbus Circle Investors first reported a position in INFI in Q2 2013 and held it in 3 quarters. The position peaked at $1.9M in Q3 2013. 98 funds tracked by Wall St. Rank hold INFI as of Q1 2014.

  • Columbus Circle Investors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 22,857 Infinity Pharmaceuticals, Inc. shares in Q1 2014, an estimated $316K.
  • Columbus Circle Investors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Columbus Circle Investors's Infinity Pharmaceuticals, Inc. position peaked at $1.9M in Q3 2013.
  • 98 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2014.

Based on Columbus Circle Investors's 13F filing for Q1 2014, filed 24 Apr 2014.